0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Atrophoderma Vermiculatum A Cutaneous Feature of Loeys-Dietz Syndrome FREE

Fleur S. van Dijk, MD, PhD1; Helen Brittain, MD, PhD2; Ragna Boerma, MD3; Marie L. Robert, MD, PhD2; Jan M. Cobben, MD, PhD3
[+] Author Affiliations
1Department of Clinical Genetics, VU Medical Center, Amsterdam, the Netherlands
2Department of Clinical Genetics, Guy’s and St Thomas’ NHS Foundation Trust, London, England
3Department of Pediatrics, Academic Medical Center (AMC) University Hospital, Amsterdam, the Netherlands
JAMA Dermatol. 2015;151(6):675-677. doi:10.1001/jamadermatol.2014.4900.
Text Size: A A A
Published online

Atrophoderma vermiculatum (AV) is a rare skin disorder, typically presenting in childhood with a reticular pattern of skin atrophy on the cheeks, preauricular area, and forehead that seems to result from inflammation around follicular plugs. The causative mechanism leading to AV is unclear. It can present as an isolated skin manifestation, or AV can be part of other conditions including genetic disorders.1 Herein we report the association of AV with TGFBR2-related Loeys-Dietz syndrome (LDS).

REPORT OF CASES

Patient 1

A 12-year-old boy with cardiac (widened aortic root and pulmonary artery, patent ductus arteriosus) and skeletal abnormalities (sagittal craniosynostosis, thoracic scoliosis, lordosis, pectus excavatum, long extremities, vertical talus, varus deformity, hyperlaxity) was diagnosed with LDS. Furthermore, dysmorphic facial features, amelogenesis imperfecta, and a high arched palate with lobulated uvula were also noted. A de novo pathogenic mutation in TGFBR2 (c.1639G>C p.Asp547His) was identified. At age 4 years, the patient had developed atrophic skin lesions on both cheeks, which stabilized after a few months of progression. At age 10 years, both cheeks showed reticulate atrophic lesions with a few follicular papules, which was diagnosed as AV (Figure, A).

Place holder to copy figure label and caption
Figure.
Clinical Images of 2 Patients With Atrophoderma Vermiculatum (AV) and Loeys-Dietz Syndrome

A, Close-up of cheek of patient 1 shows AV on both cheeks; a few follicular plugs can be observed. B, Full facial image of patient 2, age 11 years, shows sparse hair, receding frontal hair line, and a thin nose with hypoplastic alae nasi.

Graphic Jump Location
Patient 2

A 12-year-old boy (Figure, B) had been born with a cleft palate, associated Pierre Robin sequence, and talipes equinovarus. At age 6 years, he was noted to have mild reticulate scarring fitting the diagnosis of AV on both cheeks as well as milia in the infra-orbital region and the auricles. He also had cardiac (enlarged aortic annulus and aortic sinuses, aortic root dilatation, and bilateral carotid artery tortuosity) and skeletal abnormalities (postural scoliosis, mild pectus excavatum, metatarsus varus, joint hypermobility, bilateral fifth finger clinodactyly, and clinodactyly of left proximal interphalangeal joints II and III) and was diagnosed with LDS. In addition, a left inguinal hernia and a bifid uvula were documented. A de novo heterozygous mutation in TGFBR2 (c.1546_1557del12bp; p.Val516_Asp519del) was identified.

DISCUSSION

Both of the described patients had AV and LDS due to heterozygous TGFBR2 mutations; LDS is characterized by aggressive arterial aneurysms and widespread systemic involvement. To our knowledge, only 2 patients with AV and an aortic aneurysm syndrome have been reported in the literature. The first, a 14-year-old boy, was evaluated for Marfan syndrome, but genetic analysis of the FBN1 gene was not completed at the time of publication.2 The second, 24-year-old patient, was included in a study of 25 patients with LDS.3 She had multiple facial milia around the eyes and malar AV. A mutation in TGFBR2 was identified. Of additional interest, 3 other patients in that same study also had facial milia and a TGFBR2 mutation.3 Therefore, milia may be a feature of TGFBR2-related LDS.

Both AV and LDS are quite rare, so the association of these 2 conditions in several cases does not seem simple coincidence. It is difficult to explain the occurrence of AV in patients with LDS. The pathogenesis of LDS is aberrant TGF-β signaling due to mutations in TGFBR1/2, but many questions still remain. Similarly, the pathogenesis of AV is largely unknown.

It has been hypothesized that the keratinocytes in patients with AV mediate release of inflammatory cytokines in response to the plug formation. This inflammation then leads to fibrosis and atrophy.4 It may be that TGF-β signaling may also be involved because it is known that TGF-β signaling plays an important role in wound healing and scar formation. In LDS, atrophic scars and delayed wound healing have been reported.5 Interestingly, TGFBR1 null mutations cause multiple self-healing squamous epithelioma (MSSE)6 with subsequent atrophic scarring, which is also typical for AV. However, patients with MSSE do not have features of LDS, which is usually caused by missense mutations in the TGFBR1- or TGFBR2-kinase domain.5 Further investigations are needed to clarify the relationship between AV and LDS.

In conclusion, it appears that AV should be added as a cutaneous feature of LDS, possibly more specifically TGFBR2-related LDS. In view of the crucial importance of early detection and management of aortopathy in LDS, we suggest a careful evaluation for clinical features of LDS, including cardiac ultrasonography and possibly TGFBR1/2 DNA analysis in every patient presenting with AV.

ARTICLE INFORMATION

Corresponding Author: Jan M. Cobben, MD, PhD, Department of Pediatrics, AMC University Hospital, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands (j.m.cobben@amc.uva.nl).

Published Online: January 7, 2015. doi:10.1001/jamadermatol.2014.4900.

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank the affected individuals and their families for their kind cooperation. Also, we thank our colleagues Alessandra Maugeri, PhD, Gerard Pals, PhD (Department of Clinical Genetics, VU Medical Center), Ad P. Backx, MD, PhD (Department of Pediatric Cardiology, AMC University Hospital), John M. Simpson MD, PhD (Department of Pediatric Cardiology, Guy’s and St Thomas’ NHS Foundation Trust), and Maritza A. Middelkamp-Hup, MD (Department of Dermatology, AMC University Hospital) for their help with interpretation of data.

REFERENCES

Luria  RB, Conologue  T.  Atrophoderma vermiculatum: a case report and review of the literature on keratosis pilaris atrophicans. Cutis. 2009;83(2):83-86.
PubMed
Harper  JI, Sidwell  RU.  Vermiculate atrophoderma in a boy with Marfan syndrome. Br J Dermatol. 1999;141(4):750-752.
PubMed   |  Link to Article
Lloyd  BM, Braverman  AC, Anadkat  MJ.  Multiple facial milia in patients with Loeys-Dietz syndrome. Arch Dermatol. 2011;147(2):223-226.
PubMed   |  Link to Article
Baden  HP, Byers  HR.  Clinical findings, cutaneous pathology, and response to therapy in 21 patients with keratosis pilaris atrophicans. Arch Dermatol. 1994;130(4):469-475.
PubMed   |  Link to Article
MacCarrick  G, Black  JH  III, Bowdin  S,  et al.  Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576-587.
PubMed   |  Link to Article
Goudie  DR, D’Alessandro  M, Merriman  B,  et al.  Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet. 2011;43(4):365-369.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure.
Clinical Images of 2 Patients With Atrophoderma Vermiculatum (AV) and Loeys-Dietz Syndrome

A, Close-up of cheek of patient 1 shows AV on both cheeks; a few follicular plugs can be observed. B, Full facial image of patient 2, age 11 years, shows sparse hair, receding frontal hair line, and a thin nose with hypoplastic alae nasi.

Graphic Jump Location

Tables

References

Luria  RB, Conologue  T.  Atrophoderma vermiculatum: a case report and review of the literature on keratosis pilaris atrophicans. Cutis. 2009;83(2):83-86.
PubMed
Harper  JI, Sidwell  RU.  Vermiculate atrophoderma in a boy with Marfan syndrome. Br J Dermatol. 1999;141(4):750-752.
PubMed   |  Link to Article
Lloyd  BM, Braverman  AC, Anadkat  MJ.  Multiple facial milia in patients with Loeys-Dietz syndrome. Arch Dermatol. 2011;147(2):223-226.
PubMed   |  Link to Article
Baden  HP, Byers  HR.  Clinical findings, cutaneous pathology, and response to therapy in 21 patients with keratosis pilaris atrophicans. Arch Dermatol. 1994;130(4):469-475.
PubMed   |  Link to Article
MacCarrick  G, Black  JH  III, Bowdin  S,  et al.  Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576-587.
PubMed   |  Link to Article
Goudie  DR, D’Alessandro  M, Merriman  B,  et al.  Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet. 2011;43(4):365-369.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

823 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs